Mouse thyroid gland changes in aging: Implication of galectin-3 and sphingomyelinase by Traina, Giovanna et al.
Research Article
Mouse Thyroid Gland Changes in Aging: Implication of
Galectin-3 and Sphingomyelinase
Giovanna Traina,1 Samuela Cataldi,1 Paola Siccu,2 Elisabetta Loreti,2 Ivana Ferri,2
Angelo Sidoni,2 Michela Codini,1 Chiara Gizzi,1 Marzia Sichetti,1
Francesco Saverio Ambesi-Impiombato,3 Tommaso Beccari,1 Francesco Curcio,3
and Elisabetta Albi1
1Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
2Division of Anatomic Pathology and Histology, Department of Experimental Medicine, School of Medicine and Surgery,
University of Perugia, Perugia, Italy
3Department of Medica Area, University of Udine, P.le M. Kolbe 4, 33100 Udine, Italy
Correspondence should be addressed to Elisabetta Albi; elisabetta.albi@unipg.it
Received 29 August 2017; Accepted 12 November 2017; Published 11 December 2017
Academic Editor: Fabiola Olivieri
Copyright © 2017 Giovanna Traina et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is properly cited.
Prevalence of thyroid dysfunction and its impact on cognition in older people has been demonstrated, but many points remain
unclariﬁed. In order to study the eﬀect of aging on the thyroid gland, we compared the thyroid gland of very old mice with that
of younger ones. We have ﬁrst investigated the changes of thyroid microstructure and the possibility that molecules involved in
thyroid function might be associated with structural changes. Results from this study indicate changes in the height of the
thyrocytes and in the amplitude of interfollicular spaces, anomalous expression/localization of thyrotropin, thyrotropin receptor,
and thyroglobulin aging. Thyrotropin and thyrotropin receptor are upregulated and are distributed inside the colloid while
thyroglobulin ﬁlls the interfollicular spaces. In an approach aimed at deﬁning the behavior of molecules that change in diﬀerent
physiopathological conditions of thyroid, such as galectin-3 and sphingomyelinase, we then wondered what was their behavior
in the thyroid gland in aging. Importantly, in comparison with the thyroid of young animals, we have found a higher expression
of galectin-3 and a delocalization of neutral sphingomyelinase in the thyroid of old animals. A possible relationship between
galectin-3, neutral sphingomyelinase, and aging has been discussed.
1. Introduction
Galectins are a family of proteins with speciﬁc domains of
130 amino acids able to bind β-galactosides [1]. 15 mamma-
lian galectins are classiﬁed into three groups: prototype galec-
tins, tandem galectins, and chimera-type group, of which
galectin-3 (Gal-3) is the only member [2]. Gal-3 is widely dis-
tributed in a large number of tissues, and at the cellular level,
it can be located in the membranes, cytoplasm, and nucleus
[3]. Gal-3 is known to modulate many immune reactions
[4]. It can be released extracellularly under diﬀerent inﬂam-
matory stimuli like lipopolysaccharide, known to induce
upregulation of Gal-3 expression [5]. Moreover, Gal-3 plays
a role in leukocyte recruitment to the inﬂamed microcircula-
tion [6]. Recent evidence shows that Gal-3 plays a role in
numerous pathologic conditions such as inﬂammation [7],
metabolic disorders [8], and cancer [9]. In humans, Gal-3 is
upregulated in malignant thyroid neoplasms as compared
to benign neoplasms and in particular in papillary thyroid
carcinoma (PTC), the most prevalent type of malignant
tumor of the endocrine system [10]. In rats, the microgravity
induces the upregulation of Gal-3 in thyrocytes as well as its
release in colloid [11].
Increasing studies demonstrate that neutral sphingo-
myelinase (nSMase), also known as sphingomyelin phos-
phodiesterase, an enzyme that uses sphingomyelin (SM)
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as a substrate to produce ceramide and phosphocholine,
may regulate many cell physiopathology processes [12].
Recently, it has been demonstrated that nSMase is upregu-
lated in aging [13]. nSMase is present in the thyrocytes of
the thyroid gland, and it is more expressed in the right than
in the left lobe [14]. In thyrocytes in culture, the nSMase
activity depends on their physiological state by inﬂuencing,
together with sphingomyelin synthase (SM-synthase), the
ceramide/diacylglycerol balance [15]. Thyroid nSMase activ-
ity is stimulated during spaceﬂight and after ionizing and
nonionizing ray treatment [16].
At the moment, nothing is known about Gal-3 and
nSMase behavior in the thyroid gland during aging and,
therefore, the aim of the present study was to investigate
this point.
2. Methods
2.1. Animals. Three CD-1 male mice six weeks old and three
CD-1 male mice eighteen months old (Harlan Laboratories
Srl, Correzzana D’Adda, Milan, Italy) were used. Mice were
kept under a 12-hour light/dark cycle and housed under con-
trolled conditions as reported in Traina et al. [17]. Mice had
free access to pelleted food and water. The weight was 26± 3 g
and 47± 2 g for young and old animals, respectively.
2.2. Ethical Approval. The experimental protocol was
approved by the Ethical Committee for Animal Experimen-
tation at the University of Perugia, Italy. Animal care was
in compliance with Italian regulations (Ministerial Declara-
tion 04.03.2014 n°26), as well as with European Economic
Community regulations (O.J. of European Commission
2010/63/UE).
2.3. Reagents. Anti-TSH receptor (TSHR), anti-nSMase, and
ﬂuorescein isothiocyanate- (FITC-) conjugated secondary
antibody were obtained from Santa Cruz Biotechnology
Inc. (California, USA). TSH, thyroglobulin, and Gal-3 anti-
bodies were from Leica Biosystems (Newcastle Ltd., UK).
2.4. Thyroid Tissue Treatment. The thyroid tissue was ﬁxed in
4% neutral phosphate-buﬀered formaldehyde solution for
24 h, as previously reported [14]. 4μm thick sections were
prepared and mounted on silane-coated glass slides, two for
a slide at a distance equal to 140μm. Between 7 and 24 pairs,
sections were sampled excluding the ﬁrst and the last; sec-
tions 7, 13, and 19 were used for hematoxylin-eosin staining;
8, 14, and 20 for TSH detection; 9, 15, and 21 for thyroglob-
ulin detection; 10, 16, and 22 for TSHR detection; 11, 17, and
23 for Gal-3 detection; and 12, 18, and 24 for nSMase detec-
tion. Tissue sections were deparaﬃnized and rehydrated with
a series of xylene and ethanol washes.
2.5. Morphological Analysis. The sections were stained by the
hematoxylin-eosin (Chroma-Gesellschaft, Germany) stain-
ing method and investigated by using an inverted micro-
scope, EUROMEX FE 2935 (ED Amhem, The Netherlands),
equipped with a CMEX 5000 camera system (40x magniﬁ-
cation), as previously reported [14]. The morphometric
analysis was performed by using ImageFocus software.
2.6. Immunohistochemical Analysis. To remove paraﬃn from
tissue sections before rehydration and immunostaining on
the Bond automated system (Leica Biosystems Newcastle
Ltd., UK), Bond Dewax solution was used as previously
reported [14]. Immunostaining detection was performed
by using TSH, thyroglobulin, and Gal-3 antibodies. Bond
Polymer Reﬁne Detection was from Leica Biosystems
(Newcastle Ltd., UK) [14]. The images were investigated
by using microscopy as reported for morphological analysis
at 40x magniﬁcation.
2.7. Immunoﬂuorescence Analysis. After 3 washes with
phosphate-buﬀered saline (PBS), sections were incubated
with 2μg/ml anti-TSHR or anti-nSMase primary antibodies
diluted in a 0.5% solution of bovine serum albumin (BSA)
in PBS overnight at 4°C. The slides were washed 3 times with
PBS and incubated with ﬂuorochrome-conjugated secondary
antibodies for 1 hour at room temperature. Then, after 3
washes with PBS, the slides were mounted with glycerol
and coverslips. The samples were examined under a ﬂuo-
rescence microscope (OLYMPUS IX 51) equipped with
an OLYMPUS DP 50 camera system and analyzed at
40x magniﬁcation.
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Figure 1: Thyroid morphology in aging. The analysis was
performed with hematoxylin-eosin staining. Although some
thyroid follicles of old animals appear wider than those of young
mouse thyroid, the size of the follicles is not at all homogeneous.
The morphometric analysis was performed by using ImageFocus
software. Data are reported as mean± S.D. of three independent
experiments performed in duplicate. The results are not
statistically signiﬁcant, as reported in the results. Notably, the
structure of thyrocytes and interfollicular spaces appears diﬀerent
in young and old thyroid mice. In particular, thyrocytes are less
tall (red arrows) and interfollicular spaces are smaller (black
arrows) in old than in young animals. 40x magniﬁcation.
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2.8. Statistical Analysis. Three experiments were performed
for each analysis. Data are expressed as mean± SD, and t-test
was used for the comparison between young and old mice.
3. Results and Discussion
3.1. Results. In order to study the eﬀect of aging on the
thyroid gland, we have ﬁrst investigated the changes of the
microstructure. Morphometric analysis, performed on the
thyroid of young and old mice subjected to hematoxylin-
eosin staining, shows diﬀerences in length of the major axis
and of the minor axis of follicles. Since the size of the follicles
is not at all homogeneous, the results are not statistically sig-
niﬁcant (Figure 1). Changes in thyrocyte height and in inter-
follicular space amplitude are evident. In particular,
thyrocytes are less tall and consequently the thyroid epithe-
lium versus colloid volumetric ratio is reduced. Interfollicular
cells are poorer in old than in young animals (Figure 1).
Then, we have tested the possibility that molecules involved
in thyroid function might be associated with structural
changes. Figure 2(a) shows a high content of TSH in old ani-
mals accompanied by its abnormal localization in colloid.We
next asked whether increasing TSH content in old animals
might be associated with modiﬁcations of TSHR. To address
this question, the immunoﬂuorescence analysis was per-
formed by using speciﬁc antibodies against TSHR. Our
results demonstrated that the aging induces an increase of
TSHR with disordered localization in the thyrocytes, within
the follicles, and in the interfollicular spaces (Figure 2(b)).
In Figure 3, a strong labeling of thyroglobulin in an interfol-
licular space is evident in old animals. Since the Gal-3 has
been shown to change in the pathological conditions [18],
we wondered if this also occurs in aging. To this end, we
applied the immunohistochemistry analysis to measure the
content and distribution of Gal-3 in the thyroid tissue. We
found that the level of Gal-3 is increased in old animals and
especially it is abundant in colloid (Figure 4). Following the
above ﬁnding, we investigated whether nSMase was also
changed during the aging process. As shown in Figure 5,
nSMase is present in thyrocytes and accumulates in the
colloid of young animals; in aging, the nSMase ﬂuorescence
is weaker in colloid and increases in thyrocytes.
3.2. Discussion. In the human thyroid gland, there is an age-
dependent variation of follicular size and expression of
iodine transporters [19]. Sorrenti et al. have recently reported
an increase of nodular thyroid disease in the elderly [20].
Pasqualett and colleagues [21] reviewed the international
scientiﬁc literature showing an increase of TSH associated
with a reset of the hypothalamus-pituitary-thyroid (HPT)
axis. A prompt diagnosis and treatment of HPT axis hypo-
function are strongly recommended in elderly patients
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Figure 2: Thyrotropin (TSH) and thyrotropin receptor (TSHR) in the thyroid gland from young and old mice. (a) Immunohistochemical
expression of TSH. Red arrows indicate the staining in thyrocytes, and black arrows indicate the staining in interfollicular spaces. In the
thyroid of young mice, a low positivity is evident in thyrocytes and it is absent in interfollicular spaces. Strong staining is seen in the
majority of follicles either in thyrocytes or in colloid of old mice. The positivity of staining was measured as the percentage of total area
(follicles and interfollicular spaces). Data represent the mean ± S.D. of three independent experiments performed in duplicate.
Signiﬁcance, ∗P < 0 001, versus young mice. 40x magniﬁcation. (b) Fluorescence immunostaining of thyrotropin TSHR. The intensity of
ﬂorescence is higher in old animal than in young animals. Moreover, the ﬂuorescence has a disordered localization in the thyrocytes,
within the follicles, and in the interfollicular spaces as shown by arrows. 20x magniﬁcation.
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Figure 3: Thyroglobulin in the thyroid gland from young and old mice. Immunohistochemical expression of thyroglobulin. Black arrows
indicate staining in interfollicular spaces. In the thyroid of young mice, a low positivity is evident in interfollicular spaces. Strong staining
is seen in the interfollicular spaces of old animals. The positivity of staining was measured as the percentage of total area (follicles and
interfollicular spaces). Data represent the mean ± S.D. of three independent experiments performed in duplicate. Signiﬁcance, ∗P < 0 001,
versus young sample. 40x magniﬁcation.
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[22]. Interestingly, our study showed an abnormal distri-
bution of TSH and TSHR inside the follicles. TSH is pres-
ent in great quantity in the colloid. It is possible that the
accumulation of TSH is due to a lack of hormone receptor
response. We showed that the TSHR is overexpressed in
aging but distributed in a totally disordered manner.
Moreover, the thyroglobulin ﬁlls the interfollicular spaces
which have been increased in volume with aging. The pos-
sibility that thyroglobulin is released in the interfollicular
spaces because it cannot be used for the synthesis of thy-
roid hormones cannot be excluded. In this way, our ﬁnd-
ings might support previous results showing the reduction
of thyroid hormone in the blood [19–22]. Prevalence of
thyroid dysfunction and its impact on cognition in older
adults has been described [23].
However, what molecule is involved in the structure/
function alteration of thyroid in aging remains yet unclear.
In this study, we provided strong evidence that Gal-3, known
to be overexpressed in thyroid cancer [10] by leading to the
attenuation of apoptosis [18], is upregulated and moves into
colloid during aging, an eﬀect similar to that shown in thy-
roid damage induced by microgravity conditions [11]. Our
results suggest that some thyroid changes occurring during
aging parallel modiﬁcations are associated with the onset of
thyroid gland cancer. Importantly, there are instances in
which nSMase is known to mediate alterations in diﬀerent
organs in response to aging, via ceramide production [24].
Thus, we studied the localization of nSMase in the thyroid
from young and old animals. The changes of nSMase that
result from our study could indicate its possible role in thy-
roid gland disorders induced by aging. The involvement of
nSMase in thyroid damage has been widely described.
nSMase in thyroid cells is so important that the enzyme
was considered a marker for damage induced during space
ﬂights [11]. The exact role of Gal-3 and nSMase is not clear,
but the expression levels of both molecules are known to
directly stimulate thyroid disorders, as it occurs in micro-
gravity [11]. Our data merely suggest that during aging, not
only the HPT axis, the follicular structure, and the synthesis
of thyroid hormones are altered as reported in the literature,
but also the thyroid gland takes damage similar to cancer as
well as damage similar to those induced by microgravity
and radiation.
4. Conclusions
Our data show an increase in the volume of follicles not sta-
tistically signiﬁcant, an increase in the TSH expression that
ﬁlls the colloid, and in thyroglobulin that diﬀuses in the inter-
follicular spaces. Moreover, TSHR also appears upregulated.
Notably, Gal-3 and nSMase are upregulated and delocalized
in comparison with control mice. Taken together, these data
suggest that not only the follicle structure and molecules
involved in the synthesis of thyroid hormones change in
aging, by supporting previous data [19–22], but also mol-
ecules involved in the thyroid damages, such as Gal-3
[11, 18] and nSMase [11–24]. To our knowledge, this is
the ﬁrst study correlating thyroid changes in aging and
markers of thyroid damages including cancer. Here, we
found higher expression of Gal-3 and a redistribution of
nSMase in the thyroid of old animals in comparison with
those of young animals. This body of work suggests that
Gal-3 and nSMase, by inducing thyroid changes, might be
the cause of the increased expression and altered distribution
of TSH, thyroglobulin, and TSHR or vice-versa. Future
studies will clarify this point.
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Figure 4: Immunohistochemical expression of galectin-3. Strong staining is seen in the majority of follicles and in interfollicular spaces of old
mice, as shown by arrows. The positivity of staining was measured as the percentage of total area (follicles and interfollicular spaces). Data
represent the mean ± S.D. of three independent experiments performed in duplicate. 40x magniﬁcation. Signiﬁcance, ∗P < 0 05, versus
young sample.
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Figure 5: Fluorescence immunostaining of neutral sphingomyelinase
(nSMase), by using anti-nSMase antibody in thyroid tissues of
young and old mice. The high level of ﬂuorescence is found in
the thyrocytes and colloid of young animals. With aging, the
ﬂuorescence localization increases in thyrocytes and reduces in
colloid. 20x magniﬁcation.
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